Vezugen has been developed which is oriented in correction of pathological changes in the blood vessels during many diseases. Vezugen is a peptide complex that contains amino acids that contribute to tissue repair and normalization of the functional state of blood vessels. A clinical study has shown that Vezugen preventions and treats patients with atherosclerosis of the heart, brain and lower limbs, with disturbance of microcirculation in various organs and tissues, psycho-emotional stress, as well as for prevention of vascular disease in elderly. It is established that the use of Vezugen in patients with atherosclerosis contributed to the improvement of general condition, normalization of sleep, especially in patients with vascular disorders. Patients with coronary heart disease manifestations observed decrease in cardiac arrhythmia, ischemia of angina attacks. Patients with hypertension experienced normalization of blood pressure with Vezugen in combination with antihypertensive drugs, it was possible to achieve long-term remission between the hypertensive crisis at a lower dose of conventional antihypertensive drugs.Vezugen is well tolerated by patients; there were no side effects shown, complications, contraindications and drug dependence.
Peptide complex AC-2-(lysine, glutamic acid, aspartic acid). Inactive ingredients: microcrystalline cellulose (E460), beetroot sugar, lactose, starch, Tween-80. As an additional source of peptides.
Adults: from 1 to 2 capsules, once or twice a day during food intake. Duration: 10-30 days. It is advised to repeat the procedure after 4-6 months.